Page 32 - Acrobat J Trad-21-3-2566
P. 32

J Thai Trad Alt Med                                    Vol. 21  No. 3  Sep-Dec  2023  515




            0.2% chlorhexidine mouthwash in complete    thoxycurcumin, respectively, was dissolved in
            eradication of both free-floating forms and   a solvent solution prepared by mixing 40 ml of

            biofilms of C. albicans and also enhanced   polyethylene glycol (PEG), 25 ml of 2% low mo-
            anti-inflammatory and ulcer healing activity   lecular weight chitosan (Sigma Aldrich, USA)
                        [15]
            of curcumin.  Additionally, an alcohol free   solution (chitosan 2 g in 100 ml of 1% acetic
            0.1% chitosan-0.5% curcuminoids mouthwash   acid water), 15 ml of sorbitol, 1 ml of paraben
            (CHI-CUR) has been found to be better than   concentration, and 100 µl of 10% NaOH (the
            2% chlorhexidine mouthwash in management    remaining volume was made up of water until

            of generalized or candida-associated denture   reaching 100 ml).
            stomatitis with high safety and high patient
                                      [16]
            compliance and satisfaction.                1.2 Study participants
                 Therefore, the aim of this study was to       Volunteers agreeing to participate in
            determine the therapeutic efficacy of 0.1%   the study signed the informed consent form.

            CHI-CUR mouthwash that exerts anti-inflam-  Protocol and consent forms were approved by
            matory and antifungal activity in management   the Research Ethics Committee (REC) of the
            of oral lichen planus (OLP) in comparison to a   Faculty of Dentistry, Prince of Songkla Univer-

            standard 0.1% TA mouthwash to provide its   sity (EC6112-48-J-HR). The trial number was
            clinical application as an alternative therapeu-  TCTR20200910005. The name of the registry

            tic agent for OLP.                          is the Thai Clinical Trials Registry (TCTR).
                         Methodology                         The inclusion criteria were 18 years
                                                        aged or older adults of both genders with
            1. Material                                 pathological evaluations confirming  symp-

                 1.1 Preparation of an alcohol-free 0.1%   tomatic OLP by experienced oral medicine
            chitosan-0.5% curcuminoids (CHI-CUR)        specialists, having the ability to use mouth-

            mouthwash by a pharmacist in the Depart-    wash correctly and were treated at the Den-
            ment of Clinical Pharmacy, Faculty of Phar-  tistry hospital, Prince of Songkla University,
            maceutical Sciences [16]                    Thailand.

                 0.1 g of commercial curcuminoids powder      The exclusion criteria were pregnant and
            purified from turmeric (Curcuma longa Linn.)   lactating women; patients with open mouth

            rhizome (Thai-China Flavors and Fragrances   sores because of any other diseases; patients
            Industry Co. LTD) containing 79:19:2 cur-   with oral candidiasis, HIV infections or chronic
            cumin: demethoxycurcumin and bisdeme-       systemic disease (e.g. hyperthyroidism, dia-
   27   28   29   30   31   32   33   34   35   36   37